Department of Neurology, Helsinki University Hospital, and Clinical Neurosciences, Neurology, University of Helsinki, Helsinki, Finland.
Department of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, United Kingdom; Department of Neurology, National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom.
Handb Clin Neurol. 2022;184:287-298. doi: 10.1016/B978-0-12-819410-2.00033-3.
Stroke is the commonest cause of physical disability in the world. Our understanding of the biologic mechanisms involved in recovery and repair has advanced to the point that therapeutic opportunities to promote recovery through manipulation of post-stroke plasticity have never been greater. This work has almost exclusively been carried out in rodent models of stroke with little translation into human studies. The challenge ahead is to develop a mechanistic understanding of recovery from stroke in humans. Advances in neuroimaging techniques can now provide the appropriate intermediate level of description to bridge the gap between a molecular and cellular account of recovery and a behavioral one. Clinical trials can then be designed in a stratified manner taking into account when an intervention should be delivered and who is most likely to benefit. This approach is most likely to lead to the step-change in how restorative therapeutic strategies are delivered in human stroke patients.
中风是世界上最常见的导致身体残疾的原因。我们对中风后恢复和修复所涉及的生物学机制的理解已经取得了进展,现在有了通过操纵中风后的可塑性来促进恢复的治疗机会,这在以前是从未有过的。这项工作几乎完全是在中风的啮齿动物模型中进行的,很少有转化为人类研究。摆在我们面前的挑战是要对人类中风后的恢复建立一种机械性的理解。神经影像学技术的进步现在可以提供适当的中间水平的描述,从而在恢复的分子和细胞描述与行为描述之间架起桥梁。然后可以分层设计临床试验,考虑何时进行干预以及谁最有可能受益。这种方法最有可能导致在人类中风患者中提供恢复性治疗策略方面取得重大进展。